Effect of Pentoxifylline on Microalbuminuria in Diabetic Patients: A Randomized Controlled Trial
Background. Pentoxifylline is a nonspecific phosphodiesterase inhibitor with anti-inflammatory properties. Human studies have proved its antiproteinuric effect in patients with glomerular diseases, but this study was designed to assess the effects of add-on pentoxifylline to available treatment on r...
Saved in:
Main Authors: | Shahrzad Shahidi, Marziyeh Hoseinbalam, Bijan Iraj, Mojtaba Akbari |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | International Journal of Nephrology |
Online Access: | http://dx.doi.org/10.1155/2015/259592 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Microalbuminuria in the Early Diagnosis of Kidney Damage in Diabetic Patients
by: Gabriel Ignacio Hinojoza Alarcón, et al.
Published: (2021-05-01) -
TNF-α and Microalbuminuria in Patients with Type 2 Diabetes Mellitus
by: I.-Th. Lampropoulou, et al.
Published: (2014-01-01) -
Low Serum Magnesium Level Is Associated with Microalbuminuria in Chinese Diabetic Patients
by: Baihui Xu, et al.
Published: (2013-01-01) -
Microalbuminuria and Cardiovascular Risk Factors in Diabetic Patients from a Medical Office
by: Agustín Paramio Rodríguez, et al.
Published: (2022-12-01) -
Pre-diabetes and cardiovascular risk factors in NAFLD patients: a retrospective comparative analysis
by: Azam Teimouri, et al.
Published: (2025-02-01)